Muscle scans may reveal hidden death risk in ICU shock patients
NCT ID NCT07483710
First seen Apr 29, 2026 · Last updated Jun 11, 2026 · Updated 10 times
Summary
This study looks at whether muscle size and quality measured by a CT scan can predict the risk of death within 3 months after leaving the ICU for patients with septic shock. Researchers will enroll 196 adults and analyze their muscle scans taken shortly after ICU admission. The goal is to better understand how muscle health affects recovery, but this study does not test any new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier Universitaire de Saint-Etienne
Saint-Etienne, 42055, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Clinique Mutualiste
Saint-Etienne, 42000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospices Civils de Lyon
Lyon, 69000, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.